Linfomas

GLUN

Foto de Linfomas

Foto de Hospital Universitari de Bellvitge

Hospital Universitari de Bellvitge

l'Hospitalet de Llobregat, España

Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (5)

2022

A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Leukemia and Lymphoma, Vol. 63, Núm. 1, pp. 93-100

2020

Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry
European heart journal, Vol. 41, Núm. 18, pp. 1720-1729

2016

Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients
Acta Haematologica, Vol. 136, Núm. 2, pp. 76-84

2009

Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type
Cancer, Vol. 115, Núm. 22, pp. 5210-5217

2008

Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain
Medicina Clinica, Vol. 131, Núm. 12, pp. 441-446